Hansa Biopharma is a biotechnology company. The company specializes in the research and development of enzymes, which are further used to study patients suffering from rare immunological diseases. The main business vision is to create an enzyme that inactivates antibodies for the treatment regarding organ transplantation and among unusual autoimmune diseases. Other projects focus on the development of antibody-modulating enzymes and HBP analysis.